MACCHIONI, Lara
 Distribuzione geografica
Continente #
NA - Nord America 3.253
EU - Europa 2.748
AS - Asia 1.888
SA - Sud America 312
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
AN - Antartide 1
Totale 8.244
Nazione #
US - Stati Uniti d'America 3.176
SG - Singapore 864
IE - Irlanda 517
IT - Italia 499
UA - Ucraina 390
CN - Cina 333
SE - Svezia 316
HK - Hong Kong 305
BR - Brasile 267
RU - Federazione Russa 242
DE - Germania 241
FI - Finlandia 168
VN - Vietnam 128
KR - Corea 122
GB - Regno Unito 91
FR - Francia 84
RO - Romania 58
CA - Canada 46
TR - Turchia 26
IN - India 24
PL - Polonia 24
NL - Olanda 23
CH - Svizzera 22
BE - Belgio 21
AR - Argentina 18
MX - Messico 18
BD - Bangladesh 14
ZA - Sudafrica 14
UZ - Uzbekistan 13
AT - Austria 12
EC - Ecuador 12
ES - Italia 12
IQ - Iraq 9
JP - Giappone 9
CZ - Repubblica Ceca 6
ID - Indonesia 6
MA - Marocco 6
PK - Pakistan 6
CL - Cile 5
LT - Lituania 5
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DZ - Algeria 3
GR - Grecia 3
KE - Kenya 3
NP - Nepal 3
PY - Paraguay 3
RS - Serbia 3
VE - Venezuela 3
AO - Angola 2
BN - Brunei Darussalam 2
CO - Colombia 2
CR - Costa Rica 2
EG - Egitto 2
EU - Europa 2
GT - Guatemala 2
JO - Giordania 2
MT - Malta 2
PH - Filippine 2
SA - Arabia Saudita 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
ME - Montenegro 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
UY - Uruguay 1
Totale 8.244
Città #
Chandler 614
Singapore 562
Dublin 517
Hong Kong 304
Ashburn 217
San Mateo 216
Jacksonville 201
Perugia 185
Boardman 140
Seoul 122
Munich 119
Ann Arbor 115
Santa Clara 114
Medford 96
Princeton 96
Beijing 95
Moscow 76
Wilmington 76
Bucharest 56
New York 56
Dong Ket 53
Redmond 53
Los Angeles 50
Altamura 49
Andover 49
Turku 40
Piscataway 39
Helsinki 35
Lawrence 32
Ho Chi Minh City 31
Saint Petersburg 31
Houston 23
Piediluco 23
Rome 23
Denver 22
Dallas 21
Montreal 21
Woodbridge 21
Brussels 20
Izmir 20
Warsaw 20
Hanoi 18
São Paulo 18
Atlanta 16
Auburn Hills 15
Brooklyn 15
Frankfurt am Main 14
Norwalk 14
Stockholm 14
Chennai 13
Falls Church 13
Johannesburg 13
Milan 13
Des Moines 12
Amsterdam 11
London 11
Chicago 10
Città Di Castello 9
Manchester 9
Mexico City 9
Orem 9
Phoenix 9
Redwood City 9
Rio de Janeiro 9
Tokyo 9
Boston 8
Falkenstein 8
Shanghai 8
Assisi 7
Espoo 7
Toronto 7
Belo Horizonte 6
Changsha 6
Ottawa 6
Shijiazhuang 6
Wuhan 6
Ankara 5
Baghdad 5
Columbus 5
Grugliasco 5
Guayaquil 5
Haiphong 5
Seattle 5
Tashkent 5
The Dalles 5
Betim 4
Den Haag 4
Dhaka 4
Florence 4
Frankfurt Am Main 4
Guangzhou 4
Mumbai 4
Nuremberg 4
Olomouc 4
Querétaro 4
San Francisco 4
San Paolo di Civitate 4
Southend 4
Tianjin 4
Turin 4
Totale 5.125
Nome #
Identification of a phosphatase activity, toward the phosphopeptide pyroGlu-Asp-Asp-Ser(p)-Asp-Glu-Glu-Asn, in nuclear extract from HL-60 promyelocitic leukaemia cells. 772
L’infiltrazione intradetrusoriale di tossina botulinica A riduce i livelli tissutali vescicali di nerve growth factor in pazienti affetti da iperattività detrusoriale neurogena. 209
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 165
Characterization of nuclear secretory phospholipase A2 (sPLA2) 140
Enteric glial cells are susceptible to Clostridium difficile toxin B 128
Bromopyruvate mediates autophagy and cardiolipin degradation to monolyso-cardiolipin in GL15 glioblastoma cells 126
Studio di un'attività fosfolipasica presente nei nuclei di cellule gliali e neuronali di corteccia cerebrale di ratto. 124
Activity, Expression, and Substrate Preference of the δ6-Desaturase in Slow- or Fast-Growing Rabbit Genotypes 122
Acetamidine-based iNOS inhibitors as molecular tools to counteract inflammation in BV2 microglial cells 122
Clostridium difficile toxin B induces senescence in enteric glial cells: A potential new mechanism of Clostridium difficile pathogenesis 121
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 121
Mitochondrial dysfunction and effect of antiglycolytic bromopyruvic acid in GL15 glioblastoma cells 120
Palmitate lipotoxicity in enteric glial cells: Lipid remodeling and mitochondrial ROS are responsible for cyt c release outside mitochondria 119
Selected cholesterol biosynthesis inhibitors produce accumulation of the intermediate FF-MAS that targets nucleus and activates LXRα in HepG2 cells 119
Cytochrome c redox state influences the binding and release of cytochrome c in model membranes and in brain mitochondria 117
Characterization of a phospholipase A2 present in purified nuclei from rat brain cortex . INTERNATIONAL CONFERENCE ON PHOSPHOLIPASE A2 113
3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells 109
Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum? 108
Mitochondrial localization of sPLA2-IIA in neuronal cell 107
RELEASE OF GROUP IIA SECRETORY PHOSPHOLIPASE A2 FROM RAT BRAIN MITOCHONDRIA: DOES IT CORRELATE WITH THAT OF CYTOCHROME c? 107
A Calsequestrin-1 mutation associated with a skeletal muscle disease alters sarcoplasmic Ca2+ release 106
Phospholipase A2 activity in rat brain nuclei. 104
Properties of phospholipase A2 in the nuclear fraction of rat brain cortex 104
Release of group IIA secretory phospholipase A2 from rat brain mitochondria: does it correlated with that of cytochrome c? 104
Immunolocalization of secretory phospholipases A2 (sPLA2) in neural cells 104
Rat brain release a phospholipase A2 having properties similar those of the typr II secretory enzymes 103
H2O2 disposal in cardiolipin-enriched mitochondria is due to increased cytochrome c peroxidase activity. 102
Botulinum A toxin intravesical treatment induces a reduction of nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. 96
Enteric glial cells counteract Clostridium difficile Toxin B through a NADPH oxidase/ROS/JNK/caspase-3 axis, without involving mitochondrial pathways 96
The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells 96
Localisation and properties of Phospholipases A2 in rat brain cortex mithocondria assayed with labelled E.Coli membranes as substrates. 95
EFFECT OF NGF ON PHOSPHOLIPASES A2 LOCALIZATION IN PC12 CELLS 94
Crosstalk between long-term sublethal oxidative stress and detrimental inflammation as potential drivers for age-related retinal degeneration 94
The presence of a secretory phospholipase A2 in the nuclei of neuronal and glial cells of rat brain cortex. 93
Bladder tissue levels of nerve growth factor in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 93
Characterization of a Phospholipases A2 present in purified nuclei from brain cortex 90
Brain secretory phospholipase A2: functions and roles in neurodegenerative diseases 90
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 89
Cellular and subcellular distribution of secretory PLA2 in neural cells 89
Botulinum-A toxin injections into the detrusor muscle reduce nerve growth factor bladder tissue levels in patients affected by neurogenic detrusor overactivity. 89
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 88
Bladder tissue levels of NGF in SCI patients with detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 88
Cardiolipin contribution to H2O2 disposal in brain mitochondria 88
Cardiolipin-mediated temporal response to hydroquinone toxicity in human retinal pigmented epithelial cell line 87
The energy blockers 3-bromopyruvate and lonidamine: effects on bioenergetics of brain mitochondria 85
Bromopyruvate and Lonidamine against GL15 glioblastoma cells 85
Tm7sf2 gene promotes adipocyte differentiation of mouse embryonic fibroblasts and improves insulin sensitivity 85
Determination of nerve growth factor levels into human bladder wall by modified enzyme-linked immunoabsorbent assay. 83
Characterization of rat brain phospholipases A2 and their possible role in cellular signaling 83
Group B streptococcus (GBS) causes macrophage PLA2s activation and modification of phosphatidyl- serine metabolism during induction of apoptosis 83
Clostridium difficile Toxin b induces enteric glial cell death through ROS generation and activation of JNK 83
In vitro effect of nerve growth factor on the main traits of rabbit sperm 83
Cytochrome c (cyt c) redox state and release from brain mitochondria: a H2O2-cardiolipin independent mechanism. 82
BOTULINUM-A TOXIN INJECTIONS INTO THE DETRUSOR MUSCLE REDUCE NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN P A TIENTS AFFECTED BY NEUROGENIC DETRUSOR OVER- ACTIVITY 82
Distribution of secretory phospholipase A2 (PLA2) in neural cells 82
Brain secreted phospholipases A2 (sPLA2) as intra- and extra-cellular mediators 81
Brain mitochondrial phospholipases A2: functions and role in cell death 81
A channelopathy mutation in the voltage-sensor discloses contributions of a conserved phenylalanine to gating properties of Kv1.1 channels and ataxia 81
Nerve Growth Factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 79
Effect of NGF on phospholipase A2 localization in PC12 cells 79
CHARACTERIZATION OF NUCLEAR SECRETORY PHOSPHOLIPASE A2 (sPLA2) 79
Subcellular localization of secretory phospholipases A2 (sPLA2) group IIA (GIIA) and group V (GV) in neural cells 79
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study 78
The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes 78
Brain secretory phospholipases A2: role in neurodegeneration. 77
Presence of Group V Phospholipase A2 in rat brain cortex nuclei. 77
Bladder tissue levels of NGF in SCI patients with detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle. 76
Maternal dietary supplementation of n-3 fatty acids: effect on ∆6-desaturase expression and activity of suckling rabbits 76
Lethal digenic mutations in the K+channels kir4.1 (KCNJ10) and SLACK (KCNT1) associated with severe-disabling seizures and neurodevelopmental delay 75
Presence of Group V Phospholipase A2 in rat brain cortex nuclei 73
Mitochondrial and nuclear secretory phospholipases A2: potential partecipation to life or death decision of neural cells. 72
Platelet-activating factor: role in long-term potentiation d in brain damage. 72
Effect of dietary flaxseed supplementation on liver delta6-desaturase activity in two chicken genotypes 72
Palmitate lipotoxicity in enteric glial cells 72
Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity 72
Is the cytosolic phospholipase A2 the enzyme that is activated by a G- protein-mediated mechanism in human platelets and is down-regulated by protein kinase C ? 71
Nerve Growth factor bladder tissue levels in patients with neurogenic detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 70
Determination of Nerve Growth Factor levels into human bladder wall by modified enzyme-linked immunoabsorbent assay. 67
Differential protein expression in glioblastoma cells induced by 3-bromopyruvate 67
Evidence that cytosolic phospholipase A2 is down-regulated by protein kinase C in intact human platelets stimulated with fluoroaluminate. 65
Platelet-activating factor: role in long-term potentiation and in brain damage 65
Impairment of brain mitochondrial functions by ß-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine. 64
Impairment of brain mitochondrial functions by β-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine 64
Respiratory state and release of mitochondrial phospholipase A2 62
Identification of a phosphatase activity, toward the phosphopeptide PyroGlu-Asp-Asp-Ser(p)-Asp-Glu-Glu-Asn, in nuclear extract from HL-60 promyelocitic leukaemia cells. 62
Release of a phospholipase a2 from rat brain mithocondria. 61
Release of secretory typeII phospholipase A2 from rat brain cortex mitochondria depends on respiratory state 60
Phospholipase A2 release from rat brain cortex mitochondria depends on respiratory state and precedes the liberation of cytochrome c 59
Livelli tissutali di Nerve growth factor nella ipertrofia prostatica benigna ed iperattività detrusoriale dopo terapia con tamsulosina. 59
Long-term effects of silver nanoparticles on reproductive activity of rabbit buck 59
Rat brain cortex mitochondria release group II secretory phospholipase A(2) under reduced membrane potential. 55
Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases. 55
Role of protein kinase C in the release of arachidocic acid from platelets 54
Livelli tissutali vescicali di Nerve Growth Factor nella Ipertrofia Prostatica Benigna ed iperattività detrusoriale dopo terapia con Tamsulosina. 52
Localizzazione e proprietà delle fosfolipasi A2 nelle frazioni subcellulari della corteccia cerebrale di ratto 52
Localization and effect of ammodytoxin in PC12 cells. 46
NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND DETRUSOR OVER ACTIVITY TREATED WITH TAMSULOSIN 42
Evaluation of the gene expression and Δ6-desaturase activity in different chicken strains 29
null 27
Totale 9.263
Categoria #
all - tutte 36.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021442 0 0 0 0 0 61 73 18 103 41 71 75
2021/20221.697 19 908 18 59 38 7 17 221 11 115 132 152
2022/20231.632 111 230 16 172 129 158 4 94 643 4 52 19
2023/2024639 40 53 34 8 16 7 188 24 66 11 111 81
2024/20251.527 49 148 64 106 175 66 61 110 279 83 241 145
2025/20261.698 219 217 171 569 453 69 0 0 0 0 0 0
Totale 9.263